Compare Stocks: INMD vs. AVNS vs. CERS vs. TMCI

Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
INMDAVNSCERSTMCI
+6.26%+90.91%+5.58%+124.76%

Market Snapshot

Current market context for the selected companies.

Performance

Absolute returns and relative performance versus SPY.

Metric INMDAVNSCERSTMCI
1 Month-3.5%+0.2%-6.0%+17.7%
1 Month vs SPY-6.8%-3.2%-9.3%+14.4%
3 Months+8.1%+1.1%-2.7%+62.8%
3 Months vs SPY+6.1%-0.9%-4.7%+60.8%
6 Months+6.9%+90.8%+13.4%+131.4%
6 Months vs SPY-3.5%+80.3%+3.0%+120.9%
1 Year+2.5%+106.4%+114.5%-36.8%
1 Year vs SPY-16.7%+87.2%+95.3%-56.0%
2 Years-6.7%+13.6%+21.5%-26.8%
2 Years vs SPY-43.3%-22.9%-15.1%-63.4%

Growth & Profitability

Operating growth, margins and capital efficiency.

Metric INMDAVNSCERSTMCI
Revenue Growth0.0%8.8%9.5%-4.2%
Earnings Growth-31.0%-21.7%
Gross Margin76.5%50.0%52.0%79.5%
Operating Margin12.8%5.4%-3.2%-33.0%
Net Margin20.7%-10.4%-3.1%-29.0%
Return on Equity12.3%-9.2%-10.8%-72.0%
Return on Assets6.2%0.9%-0.5%-17.3%

Valuation

Common valuation multiples shown side by side.

Metric INMDAVNSCERSTMCI
P / E12.5
Forward P / E11.020.0-544.0-5.7
P / S2.31.62.41.4
P / B1.41.57.74.2
EV / Sales1.01.72.51.5
EV / EBIT8.132.3-78.6-4.6
P / FCF18.368.7619.4-45.5
FCF Yield5.5%1.5%0.2%-2.2%

Cash Flow & Balance Sheet

Cash generation and leverage context.

Metric INMDAVNSCERSTMCI
Free Cash Flow$47.40M$17.05M$875.25K-$6.25M
Operating Cash Flow$83.58M$36.70M$2.42M-$14.58M
Debt / Equity0.7%17.7%108.6%107.8%

Earnings Outlook

Upcoming earnings expectations when available.

Metric INMDAVNSCERSTMCI
Next Earnings2026-11-042026-11-05
EPS Estimate0.32-0.25
Revenue Estimate91.59M47.71M
EPS Growth-15.3%-12.8%
Revenue Growth-1.7%-5.0%
Analyst Coverage51